Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -100.81% | 200.68% | -229.09% | 5.02% | 6.39% |
| Total Depreciation and Amortization | 11.74% | 13.27% | 8.56% | 7.34% | -8.00% |
| Total Amortization of Deferred Charges | 136.34% | 80.58% | 52.53% | 10.05% | 26.47% |
| Total Other Non-Cash Items | -1.55% | -1,105.56% | 1,587.17% | 19.09% | 108.24% |
| Change in Net Operating Assets | -33.86% | -94.32% | -168.92% | -56.10% | 43.78% |
| Cash from Operations | -1,413.09% | -208.12% | -136.57% | 4.30% | 122.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -2,400.00% | -- | -- | 1.49% |
| Cash from Investing | -100.00% | -2,400.00% | -- | -90.07% | 1.49% |
| Total Debt Issued | 119.30% | 169.02% | 87.63% | 70.41% | -42.83% |
| Total Debt Repaid | 38.66% | -45.92% | -23.15% | -37.57% | -2.90% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 430.13% | 300.21% | 138.61% | 101.17% | -204.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -- |